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 Mucosal Macrophages in Intestinal 
Homeostasis and Inflammation 
 Allan McI Mowat    Calum C. Bain 
 Institute of Infection, Immunology and Inflammation, University of Glasgow,  Glasgow , UK 
tween these resident and inflammatory macrophages is crit-
ical for maintaining the status quo in healthy gut and ensur-
ing protective immunity when required. 
 Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Macrophages (m  ) are one of the most abundant leu-
cocytes in the intestine of all mammalian species and this 
is probably the largest population of mononuclear phago-
cytes in the body  [1] . M  are found throughout the intes-
tinal tract of all mammals, both in the mucosa and deep-
er layers such as the submucosa and muscularis mucosae. 
However, they are found in greatest numbers in the lam-
ina propria which forms the core of the mucosa underly-
ing the surface epithelium ( fig. 1 ). They are rare in the 
epithelium itself, although some specialised populations 
of mononuclear leucocytes may be able to send processes 
through the epithelium from the lamina propria to sam-
ple luminal contents (see below). Although few detailed 
studies have been conducted, mucosal m  numbers in 
different parts of the intestine appear to correlate closely 
with the relative bacterial load and thus are highest in the 
colon, where the number of commensal bacteria is in ex-
cess of 10 12 organisms/ml  [2] . Their numbers are also de-
creased in the intestine of germ-free mice  [3] . Interest-
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 Abstract 
 Intestinal macrophages are essential for local homeostasis 
and in keeping a balance between commensal microbiota 
and the host. However, they also play essential roles in in-
flammation and protective immunity, when they change 
from peaceful regulators to powerful aggressors. As a result, 
activated macrophages are important targets for treatment 
of inflammatory bowel diseases such as Crohn’s disease. Un-
til recently, the complexity and heterogeneity of intestinal 
macrophages have been underestimated and here we re-
view current evidence that there are distinct populations of 
resident and inflammatory macrophages in the intestine. We 
describe the mechanisms that ensure macrophages remain 
partially inert in the healthy gut and cannot promote inflam-
mation despite constant exposure to bacteria and other 
stimuli. This may be because the local environment ‘condi-
tions’ macrophage precursors to become unresponsive after 
they arrive in the gut. Nevertheless, this permits some active, 
physiological functions to persist. A new population of pro-
inflammatory macrophages appears in inflammation and 
we review the evidence that this involves recruitment of a 
distinct population of fully responsive monocytes, rather 
than alterations in the existing cells. A constant balance be-
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ingly however, m  are also frequent in more proximal 
regions of the intestine where bacteria are rare, such as 
the small intestine. 
 The intestine is exposed continuously to enormous 
amounts of antigens, some of which are potentially dan-
gerous pathogens. As prominent effector cells of both in-
nate and adaptive immune responses, m  would be ex-
pected to play important roles in protective immunity 
against such agents. Similar effector functions are en-
gaged during inappropriate inflammatory responses 
against harmless local antigens, such as those seen in in-
flammatory bowel diseases (IBD) and activated m  are 
central to the pathogenesis of these disorders. Given that 
IBD is believed to be driven by the commensal microbi-
ota that are present in large quantities in the normal large 
intestine and that m  are also always there, it is intrigu-
ing to consider why the intestine is not in a permanent 
state of inflammation. As we will discuss, this reflects a 
state of inertia in the resident m  in the normal intestine 
that allows these cells to play active and essential roles in 
maintaining epithelial integrity and mucosal homeosta-
sis. In this review, we will discuss the current knowledge 
of m  in the intestinal mucosa, highlight their pheno-
typic and functional heterogeneity and discuss how they 
may be able to play such opposing roles in healthy and 
inflamed gut.
 How to Recognise a Mucosal M  
 Mucosal m  show the morphological features of tis-
sue resident m  , with a classical mononuclear shape and 
abundant, granular cytoplasm consistent with active 
phagocytic behaviour ( fig. 1 ). In man they express the tis-
sue m  marker macrosialin (CD68) and this is also pres-
ent on most intestinal m  in mice ( fig. 2 )  [3] , together 
with the pan-m  markers F4/80, CD11b and the CSF-1 
(M-CSF) receptor (CSF-1R; CD115) ( table 1 )  [4–10] . Until 
very recently, studies of mouse mucosal m  have been 
complicated by the imprecise use of these and other 
markers to identify and purify them. Thus, relatively 
large numbers of CD11b+ F4/80+ eosinophils are present 
a
b
 Fig. 1. Location and morphology of m  in 
healthy colon.  a F4/80+ cells in control 
mouse colon and 3, 6 and 8 days after in-
duction of DSS colitis, showing the pres-
ence of m  in healthy intestine and the in-
tense infiltrate in inflammation. Repro-
duced with permission from Stevceva et al. 
[109].  b Purified F4/80+ class II MHC+ 
m  from normal mouse colon show the 
morphological appearances of activation, 
with abundant foamy cytoplasmic gran-
ules and they phagcoytose FITC-labelled 
zymosan particles.  
D
ow
nl
oa
de
d 
by
: 
Th
e 
Un
ive
rs
ity
 o
f E
di
nb
ur
gh
   
   
   
   
   
   
   
   
   
   
  
12
9.
21
5.
25
0.
14
 - 
3/
20
/2
01
5 
3:
08
:1
0 
PM
 Mowat/Bain J Innate Immun 2011;3:550–564552
in the normal mouse mucosa and it is necessary to dis-
criminate these directly from m  on the basis of high 
SSC and selective expression of Siglec F by eosinophils 
( fig. 2 ). An even greater source of inaccuracy has been the 
assumption that the expression of class II MHC and 
CD11c allows dendritic cells (DC) to be distinguished 
from m  in mouse intestine. In our hands, mature resi-
dent m  from healthy mouse colon uniformly and con-
stitutively express high levels of class II MHC ( fig. 2 ) and 
human intestinal m  have also been reported to be class 
II MHC positive  [10] . CD11c expression is also frequently 
used as a specific marker of murine DC, but well-defined 
intestinal m  can express substantial amounts of CD11c 
( table 1 ;  fig. 2 )  [7, 9, 11–14] . 
 These findings are compatible with the recent contro-
versies over the relationship between different subsets of 
mononuclear phagocyte in mice, especially in non-lym-
phoid tissues, where the distinction between DC and m  
is not as clear as in lymphoid organs  [12, 15] . Important-
ly, recent studies have shown that many of the mucosal 
cells identified previously as DC on the basis of being 
CD11c+ class II MHC+ do not have the functions of clas-
sical mucosal DC  [14] . Two major phenotypic popula-
tions of mucosal mononuclear phagocyte have now been 
proposed on the basis of expression of CD103 (  E  7 inte-
grin) and CX3CR1, the receptor for the chemokine frac-
talkine (FKN – CX3CL1) [for review, see  7, 16 ]. Although 
both populations express CD11c and class II MHC, only 
the CD103+ CX3CR1– cells possess the features of classi-
cal DC, presenting antigen to naïve T cells, migrating to 
MLN and imprinting gut homing markers and FoxP3 ex-
pression in naïve T cells via the production of retinoic 
acid (RA). Although some of these DC express the my-
eloid marker CD11b, they are F4/80– CD68–. Conversely, 
CX3CR1+ cells in the mucosa are CD103–, but are F4/80+ 
CD11b+ CD68+ and do not migrate to MLN or prime 
naïve T cells, suggesting they are likely to be m  rather 
than DC. On these grounds, we would suggest that a con-
sensus phenotype for m  in resting gut is F4/80+ CD11b+ 
CX3CR1+ CD103– class II MHC+ Siglec F– ( fig. 2 ). It re-
mains to be determined whether the same dichotomy ap-
plies in other species. Unfortunately, many of the studies 
discussed below did not use the multiparameter analyses 
that allow these subsets of mucosal mononuclear cells to 
be defined precisely and so must be interpreted with ap-
propriate caution. 
 Functions of Resident Intestinal M  
 In keeping with their activated appearance and ex-
pression of class II MHC, resident intestinal m  are 
highly phagocytic ( fig. 1 ) and they express CD36, a recep-
tor that allows phagocytic uptake of apoptotic cells  [17] . 
a
b
 Fig. 2. Phenotypic features of resident m  
in healthy mouse colon. Two major pop-
ulations of F4/80 + cells are present in pop-
ulations of live CD45+ cells isolated by 
enzymatic digestion of mouse colon. The 
F4/80 hi class II MHC hi cells are m  , as 
assessed by FSC, SSC and expression of 
CD68. Unlike resident m  in other tis-
sues, they also express very high levels 
of CX3CR1 and significant amounts of 
CD11c. The cells that express lower levels 
of F4/80 are class II MHC– and Siglec F+. 
They also have high SSC and are eosino-
phils.  
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They have also been reported to have strong bactericidal 
activity  [10] . However, they do not express high levels of 
co-stimulatory molecules such as CD80, CD86 or CD40 
 [4, 10, 11, 18, 19] . Most significantly, unlike m  from oth-
er tissues, mucosal m  do not respond to stimuli such as 
TLR ligands by producing pro-inflammatory cytokines 
or chemokines such as IL-12, IL-23, TNF-  , IL-1, IL-6 or 
CXCL10 (IP-10) nor do they up-regulate co-stimulatory 
molecules or generate a significant respiratory burst and 
nitric oxide production under these conditions  [5, 8, 10, 
20–23] . Conversely, they produce the anti-inflammatory 
cytokine IL-10 constitutively or in response to TLR liga-
tion  [5, 13, 24–26] . While paradoxical at face value, this 
split personality is of considerable physiological impor-
tance, as ingestion and killing of microbes without initi-
ating overt inflammation would allow local m  to act as 
a firewall against any commensal bacteria that have 
crossed the overlying epithelial barrier. In this respect, it 
now appears that m  are the CX3CR1+ mononuclear 
phagocytes in the small intestinal lamina propria that 
may send processes through the epithelium to capture 
bacteria in the lumen  [7, 14, 16] . Originally thought to be 
DC, these cells have never been shown to present the cap-
tured antigen to T cells. However, this luminal sampling 
appears to be required for the uptake and T cell recogni-
tion of non-pathogenic  Salmonella organisms and soluble 
proteins  [14, 27, 28] . The role of these CX3CR1+ m  may 
therefore be to pass the material on to DC for transport 
to the MLN. Alternatively, m  may degrade their cap-
tured contents in a non-inflammatory manner as dis-
Table 1.  Phenotypic comparison of murine m populations
Marker Resident
mucosal m
Inflammatory
mucosal m
Monocyte M1 m M2 m M2-like TAM
CD11b +++ +++ +++ +++ +++ +++
F4/80 +++ ++ +/– +++ +++ ++/+++
CD68 ++ ++ – ++ ++ ++
Class II MHC +++ ++/+ – ++ + ++
CD11c ++ ++ – ++ – +?
CX3CR1 +++ ++ –/++1 – – ++
CCR2 ++ +++ ++/–1 ++ ? +
Ly6C – ++ ] – ++/–1 – – –
CD40 +/– +/– – ++ – +
CD80, CD86 +/– +/– – ++ – +
CD14 ++ ++ ++ ++ ? ?
TLR2 ++ ++ +++ ++ ++
TLR4 +/– + +++ ++
MannoseR ? ? – – + ++
ScavengerR ? ? – – + ++
Phagocytosis +++ +++ + +++ +/– ++
iNOS – ++ + +++ – –
ROI – ++ + +++ – –
TNF- 8 +++ + +++ – +
IL-10 ++ 8 – – ++ ++
Arginase – –/++2 – – ++ +
COX-2 ++ ? – ++ +/– ++
IL-4R – – – – ++ –
IL-10R + – – – – ++
R esident mucosal m in resting mouse intestine are compared with the m which infiltrate during intes-
tinal inflammation, blood monocytes and the defined populations of polarised m that have been described 
in mice: M1 (‘classical’ activated), M2 (‘alternative’ activated) and M2-like (tumour associated – TAM). 
? = Not known.
1 Two subsets of monocytes are described: ‘resident’ CX3CR1+ Ly6Clo CCR2lo vs. ‘inflammatory’ CX3CR1lo 
Ly6Chi CCR2hi.
2 A population of arginase-expressing mucosal m is found in intestinal helminth infection.
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cussed above, or may migrate into the lumen itself in a 
Myd88-dependent manner, providing a layer of cellular 
innate defence  [29] .
 M  Handling of Intestinal Bacteria and Disease 
Susceptibility 
 The ability of intestinal m  to deal with local com-
mensal bacteria in an appropriate manner is essential for 
homeostasis, as genes that interfere with these processes 
are associated with susceptibility to IBD in man  [30] . 
Most notable of these is the intracellular pattern recog-
nition receptor NOD-2 present in m  that recognises 
muramyl dipeptide in peptidoglycan from bacterial cell 
walls. Around 30% of patients with small intestinal 
Crohn’s disease have a non-functional polymorphism in 
the NOD-2 gene, the strongest genetic linkage yet discov-
ered in human IBD  [31, 32] . Knock-out of NOD-2 in ex-
perimental animals has rather inconsistent effects, but 
overall, it is associated with a failure of m  to generate 
appropriate innate responses to bacteria  [31] . Autophagy 
is a further important mechanism in the control of innate 
immune responses to intracellular bacteria and viruses, 
and polymorphism in the autophagy-associated gene 
Atg16L1 has also been associated with susceptibility to 
Crohn’s disease  [33, 34] . Atg16L1 is expressed highly by 
intestinal epithelial cells and is also functional in m   [35, 
36] . The immunity-related GTPase family M (IRGM) 
protein is also involved in autophagy and innate defence 
to intracellular organisms and genetic polymorphism in 
IRGM is linked to Crohn’s disease  [37, 38] . Together these 
findings support the view that dysregulated m  respons-
es to intestinal bacteria are important factors in human 
IBD.
 Anti-Inflammatory Properties of Resident 
Intestinal M  
 Resident intestinal m  do not just contribute to intes-
tinal homeostasis by acting as a waste disposal unit for 
local bacteria, but also actively regulate epithelial integ-
rity. As a result, depletion of resident m  increases sus-
ceptibility of mice to experimental colitis and acute in-
testinal graft versus host disease  [9, 39, 40] . Among the 
mechanisms that may account for this trophic effect is 
cyclo-oxygenase 2-dependent production of prostaglan-
din E2 by m  located in the stem cell niche of the epithe-
lium  [41] . Whether this is the only mediator that enables 
mucosal m  to regulate epithelial cell renewal and 
whether m  act directly on epithelial stem cells or via 
other cell types such as mesenchymal cells remains to be 
established. Interestingly, cyclo-oxygenase 2 may also 
contribute to one further active function of intestinal 
m  , namely their production of the anti-inflammatory 
cytokine IL-10  [42] . Expression of the transcription factor 
peroxisome proliferator-activated receptor-  (PPAR-  ) 
by mucosal m  is a further mechanism by which resident 
m  can prevent local inflammation, via its ability to sup-
press pro-inflammatory gene expression  [43] and by re-
stricting CCR2-dependent entry of pro-inflammatory 
monocytes into the intestine  [44] .
 M  and Specific Tolerance to Intestinal Antigens – 
An Unexpected Alliance? 
 Recently, an additional and somewhat surprising 
physiological role for intestinal m  has emerged, namely 
in regulating antigen-specific tolerance. This was first 
suggested by evidence that F4/80 KO mice did not de-
velop tolerance or antigen-specific CD8+ regulatory T 
cells (Treg) normally after feeding soluble antigen, but 
the cellular and anatomical processes underlying this de-
fect were not determined  [45] . CD11b KO mice also have 
a defect in oral tolerance, but this could reflect the ab-
sence of either m  or CD11b+ DC  [46] . More recent stud-
ies have shown that m  -derived IL-10 is important for 
maintaining local regulatory T cell differentiation in the 
intestine and that this is needed to prevent inflammatory 
reactions against commensal bacteria and food proteins 
 [5, 13, 25] . As these m  cannot migrate to meet naïve 
CD4+ T cells in MLN in the resting condition, their role 
may be to maintain the survival of Treg in the mucosa. 
This idea has been confirmed by recent elegant studies 
which show that IL-10-producing CX3CR1+ m  in the 
small intestinal mucosa are needed for the induction of 
local and systemic tolerance after feeding protein anti-
gens  [25] . In these experiments, tolerance was associated 
with FoxP3+ Treg whose differentiation was initiated in 
the MLN by antigen loaded, RA producing CD103+ DC. 
Having acquired gut homing markers, the Treg exited the 
MLN and migrated to the mucosal lamina propria where 
further clonal expansion and terminal differentiation oc-
curred under control of IL-10-producing CX3CR1+ m  . 
This result is reminiscent of other recent work which sug-
gests that effector T cell differentiation in tissues such as 
the skin may require two separate ‘hits’ from antigen and 
APC, one in the draining LN and the second via DC in 
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the tissue itself  [47] . Resident human mucosal m  have 
been found to produce CCL20 (MIP3  ) whose ligand 
CCR6 is expressed on FoxP3+ Treg and this may encour-
age local interactions between m  and Treg in the healthy 
gut  [48] . Interestingly both the generation of Treg and 
tolerance were absent in CX3CR1 KO mice, not because 
CX3CR1+ m  failed to accumulate in the mucosa, but 
because they could not produce IL-10 once there  [25] . To-
gether these findings support a critical role for mucosal 
m  in shaping local and systemic immune responses to 
intestinal antigens. 
 Intestinal M  and Their Relatives 
 A number of functional m  subsets have been de-
scribed in mice, including ‘classical’ (M1) and ‘alterna-
tively’ activated (M2) m  which contribute to Th1- and 
Th2-mediated forms of immune response, respectively, 
by producing distinctive patterns of mediators ( table 1 ). 
Within the M2 population there is also a group of m  
with immunoregulatory and anti-inflammatory proper-
ties that are very similar to those of resident mucosal m  . 
These ‘M2-like’ m  express CD163 and CD206 lectin re-
ceptors, and produce IL-10 as well as tissue remodelling 
factors such as VEGF, metalloproteinases and activin. In 
parallel, they cannot produce pro-inflammatory media-
tors in response to stimulation  [49, 50] . Often found in-
filtrating tumours and during tissue repair, these ‘M2-
like’ cells are also usually class II MHC+ and phagocytic, 
underlining their similarity to mucosal m   [10, 50] . 
Thus, m  in the healthy intestine may be part of a func-
tional subset involved in the physiological processes of 
tissue remodelling and prevention of inflammation 
against commensal microbes. 
 Mechanisms of Inertia in Mucosal M  
 The molecular reasons underlying the functional in-
ertia of mucosal m  remain to be established with cer-
tainty, although a number of possibilities have been pro-
posed. Many studies have focussed specifically on their 
inability to respond to TLR ligands and several reports 
suggested that resident intestinal m  in both humans 
and mice failed to express TLR or associated receptors 
such as CD14 that are normally present at high levels on 
monocytes and m   [4, 8, 10, 21, 51–53] . However, there 
is now considerable evidence to suggest that these cells 
express many, if not all TLR both at the mRNA and pro-
tein level  [10, 54] . In our hands, murine resident colon 
m  express high levels of surface TLR2 protein, yet are 
unresponsive to stimulation via TLR2 ligands [unpubl. 
observations]. The position with CD14 is less clear, as 
most mouse intestinal m  express high levels of this mol-
ecule, whereas human m  may not  [10, 14] . What is clear 
is that there is a functional block in signalling through 
the TLR receptor pathways in intestinal m  and they fail 
to activate and translocate NF-  B p65 to the nucleus in 
response to appropriate stimuli  [54] . Several mechanisms 
have been proposed to explain these defects, including 
absence of a number of downstream effectors and adapt-
ers in the TLR signalling cascade, such as MyD88, IL-1 
receptor-associated kinase (IRAK), IRF2, TRAF-6 and 
TRIF-associated adapters  [54–56] . Other abnormalities 
that have been reported include expression of the IRAK-1 
inhibitor, IRAK-M  [57] , and failure to express gp96. This 
estrogen receptor-associated chaperone is required for 
folding and shuttling TLR to the cell surface or endo-
somes  [58, 59] . Over-expression of the E3 ubiquitin-pro-
tein ligase, Triad3A, which mediates degradation of some 
TLR has also been reported  [60] , as has induction of 
SOCS1 inhibitor of TLR signalling  [54] .
 It is important to recognise that the functional hypo-
responsiveness of intestinal m  extends beyond TLR li-
gation and applies to all stimuli that have been explored. 
These include ligands for pattern recognition receptors 
such as NOD-1/NOD-2 or C-type lectins, intact bacteria 
or apoptotic debris, IFN-  and even PMA  [10, 19, 24] . In 
addition, human intestinal m  lack expression of other 
stimulatory receptors such as Fc  RI and Fc  RIII, the 
CR3 and CR4 complement receptors  [17] , Fc  R  [52] as 
well as the triggering receptor expressed on myeloid 
cells-1 (TREM-1)  [26, 61] . The extensive nature of these 
defects makes the inertia of mucosal m  quite distinct 
from the well-known phenomenon of ‘endotoxin toler-
ance’ in which exposure to a single TLR ligand suppress-
es subsequent responses to the same ligand. Rather, there 
is a profound global extinction of stimulatory potential 
in mucosal m  that ensures they do not respond inap-
propriately to any of the potentially inflammatory con-
stituents of their environment. 
 Does Homeostatic Inertia of Intestinal M  Require 
TLR Ligation? 
 Despite the lack of overt inflammation in the intestine 
and the general unresponsiveness of mucosal m  to TLR 
stimulation, there is considerable evidence that their state 
D
ow
nl
oa
de
d 
by
: 
Th
e 
Un
ive
rs
ity
 o
f E
di
nb
ur
gh
   
   
   
   
   
   
   
   
   
   
  
12
9.
21
5.
25
0.
14
 - 
3/
20
/2
01
5 
3:
08
:1
0 
PM
 Mowat/Bain J Innate Immun 2011;3:550–564556
of inertia may require prior TLR ligation. TLR signalling 
in both epithelial cells and m  is essential for protecting 
the intestinal epithelium against mechanical and toxic 
insults  [62–64] . In addition, our recent findings suggest 
that there may be a low level of constitutive production of 
TNF-  by resident colonic m  [unpubl. observations]. It 
is possible that this does not go on to cause pathology be-
cause it is normally balanced by the concomitant consti-
tutive production of IL-10 or by the effects of TGF-  
 discussed above. Work on tumour-infiltrating m  has 
shown that their regulatory phenotype may reflect NF-
  B-mediated activation of anti-inflammatory pathways 
due to TLR ligation in the context of special microenvi-
ronmental factors such as extracellular matrix or hypox-
ia  [65] . However, very recent studies suggest that TLR and 
local bacteria may not be essential for the inertia in mu-
cosal m  , as it can be seen in the sterile gut during foetal 
development, secondary to local production of TGF-  
 [66] . Thus, a number of mechanisms may ensure that any 
pro-inflammatory responses are extinguished sufficient-
ly rapidly to avoid damage in the normal intestine. 
 Local Conditioning of M  Function in the Intestine 
 As the most likely origin of mucosal m  is blood mono-
cytes (see below) and these are fully responsive to stimula-
tion, it is probable that factors in the intestinal environ-
ment may be responsible for ‘conditioning’ intestinal m  
to become unresponsive after their arrival in the gut. 
There are many possible candidates for this activity, but 
IL-10 and TGF-  stand out. In conjunction, these cyto-
kines can reproduce TLR or NOD-2 unresponsiveness and 
they down-regulate TREM-1 and CD89 expression in hu-
man blood monocytes  [61, 67, 68] . As we have noted, IL-10 
is produced constitutively by mucosal m  themselves and 
there are also large numbers of IL-10-producing T lym-
phocytes in the normal intestinal mucosa  [69] . IL-10 KO 
mice develop spontaneous IBD, as do mice in which IL-10 
signalling in m  has been abolished by targeted KO of 
Stat3 in myeloid cells  [70] . Inhibiting autocrine/paracrine 
production of IL-10 by mucosal m  reverses their TLR 
unresponsiveness in vitro  [5] and the role of IL-10 is likely 
to reflect its ability to prevent NF-  B activation in m  . 
This may occur via inhibition of I  B kinase that normally 
releases NF-  B from its inhibitory partners, or by induc-
tion of mechanisms that prevent NF-  B binding to DNA 
such as the inhibitory I  B family members, I  BNS and 
Bcl-3  [19, 71, 72] . Clearly, IL-10 is an important physiolog-
ical regulator of intestinal m  function.
 TGF-  is a ubiquitous cytokine with many immuno-
modulatory and anti-inflammatory properties that are 
important in the intestine, including the maintenance 
and function of regulatory T cells and the switching of 
IgA production in naïve B lymphocytes  [73, 74] . TGF-  
is produced abundantly by many different cells in the 
mucosa, including haematopoietic cells, epithelial cells 
and mesenchymal stromal cells  [10] , and it plays impor-
tant roles in regulating epithelial cell differentiation and 
renewal  [75] . TGF-  itself is a potent inducer of M2-like 
regulatory m  differentiation  [50] and FoxP3+ Treg 
can also do this in a partially TGF-  -dependent man-
ner  [76] . As we have discussed, it is now clear that m  
interact closely with Treg in the mucosa  [25] , and recent 
studies have shown that resident human mucosal m  
express high levels of TGF-  receptors. In parallel they 
have constitutively active TGF-  signalling via the 
Smad4 transcription factor  [54] . TGF-  itself induces 
the expression of inhibitory I  B  in m  and also pro-
motes ubiquitinylation and degradation of MyD88  [76] . 
The inability of mucosal m  to activate and translocate 
NF-  B after TLR stimulation treatment can be repro-
duced in blood monocytes by treatment with TGF-  
derived from intestinal stromal cells  [54] . In addition, 
TGF-  from adult intestine prevents foetal intestinal 
m  from responding to TLR ligation  [66] . Altogether, 
these findings indicate that TGF-  derived from a num-
ber of sources is likely to be key to determining m  be-
haviour in the intestine and may be at the centre of a 
crucial two-way homeostatic interaction between m  
and Treg. Importantly, mucosa from patients with 
Crohn’s disease shows an intrinsic resistance to TGF-  
receptor signalling, indicating how dysregulation of 
this pathway may be of clinicopathological significance 
 [77] .
 A variety of other factors could be involved in condi-
tioning local m  inertia. These include mediators that 
have been shown to have similar effects on intestinal DC, 
such as RA and thymic stromal lymphopoietin  [78] , or 
agents that are produced in high quantities in the gut and 
that have been reported to drive anti-inflammatory m  
in other sites, such as vasoactive intestinal peptide  [79] . 
As noted above, CX3CL1 has been implicated in inducing 
IL-10 production by mucosal CX3CR1+ m   [25] and this 
chemokine is produced by intestinal epithelial cells in 
large quantities  [80] . Similar conditioning effects of 
CX3CL1 have been shown for m  from other tissues 
such as the brain  [81] , but contradictory reports have also 
suggested that CX3CL1 may activate m   [3] and this is-
sue needs to be examined more carefully. 
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 Inhibitory Receptors and M  Inertia 
 One further possibility we have considered to explain 
the unresponsiveness of mucosal m  is that there could 
be constitutive ligation of potentially inhibitory recep-
tors. A candidate we considered was CD200 receptor 1 
(CD200R1), an Ig superfamily molecule expressed at high 
levels on myeloid cells that recognises the ubiquitously 
expressed ligand CD200 and induces negative signalling 
by as yet unknown mechanisms  [82] . Knock-out of 
CD200 or CD200R1 leads to m  hyperactivity and auto-
immune disease in vivo  [83, 84] , and recent studies have 
shown that deleting or inhibiting the CD200-CD200R1 
interaction renders mice more susceptible to lung in-
flammation during infection with influenza virus  [85] . 
This correlates with CD200R1 expression by alveolar 
m  , a feature which is also characteristic of m  from 
resting colon ( fig. 3 ). Together with the fact that CD200R1 
can be induced by IL-10 and TGF-   [85] , this led us to 
hypothesise that lack of CD200R1 might also predispose 
to intestinal inflammation. However, preliminary results 
indicate that CD200R1 KO mice have normal intestinal 
m  populations, do not develop spontaneous IBD and 
are not more susceptible to colitis induced by oral admin-
istration of DSS ( fig.  3 ) [unpubl. observations]. Thus, 
CD200R1 does not appear to play an essential role in reg-
ulating intestinal m  behaviour.
 Finally, the intestine is rich in endogenous and exog-
enous lipid ligands for PPAR-  , and targeted deletion of 
PPAR-  in myeloid cells under the lysozyme promoter 
leads to spontaneous activation of mucosal m  as well as 
increased susceptibility to experimental colitis. In turn, 
these pathological features can be prevented in intact 
mice by administration of exogenous PPAR-  ligands 
 [44, 86] . Thus, there may be several levels of local control 
that normally ensure down-regulation of intestinal m  
function.
 Intestinal M  in Inflammation 
 The phenotype and behaviour of mucosal m  change 
dramatically during protective immune responses or in 
inflammation. Under these circumstances, there is an in-
tense infiltration of m  that express higher levels of TLR, 
CD14, co-stimulatory molecules, TREM-1 and other pro-
inflammatory receptors than their resident counterparts 
 [10, 18, 53, 87] . These m  also produce large quantities of 
mediators such as TNF-  , IL-1, IL-6, nitric oxide, reac-
tive oxygen intermediates, cathepsins and metallopro-
teases  [20, 88–91] . As a result, inflammatory m  play 
crucial roles in the pathogenesis of Crohn’s disease and 
other forms of IBD, as well as in protection against intra-
cellular infections such as salmonellosis, cryptosporidi-
osis and toxoplasmosis  [10, 92–94] . The major role of mu-
cosal m  in protective immunity is likely to be mainly as 
non-specific effector cells, rather than in initiating the 
adaptive immune responses, as the entry of and immune 
responses to fully pathogenic  Salmonella that normally 
enter via Peyer’s patches do not require CX3CR1+ muco-
sal m  to capture luminal bacteria  [95] . 
 An important but unresolved issue is whether the 
changes in m  behaviour that occur in inflammation re-
flect alterations in the normally unresponsive resident 
population, or if there is recruitment of new, fully respon-
CD200R1–/–
WT
Colonic Peritoneal
CD200R1a
WT
7.3 5.6
CD200R1–/–
F4
/8
0
TNF-
b
  
 Fig. 3. CD200R1 and intestinal m  function. Resident colonic 
m  express CD200R1 ( a ), but lack of CD200R1 does not affect the 
production of TNF-  by purified colonic F4/80 hi class II MHC hi 
m  in response to the TLR2 ligand bacterial lipopeptide ( b ). 
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sive cells ( fig. 4 ). Currently, most evidence favours the lat-
ter idea, but it is unclear if these newly arrived m  belong 
to a distinct lineage from those responsible for maintain-
ing homeostasis in the healthy intestine.
 Ontogeny and Recruitment of Intestinal M  in 
Inflammation 
 The lack of precise markers for identifying mucosal 
m  means that many studies which have attempted to 
examine their origins were focussed mostly on defining 
subsets of DC and ignored the possibility that m  might 
also have been present.
 Despite this proviso, it seems clear that inflammatory 
m  in mouse intestine are derived from a newly recruit-
ed and recently divided population of Ly6C hi blood 
monocytes ( fig. 4 ). This would be consistent with work in 
other tissues  [49, 96] and when transferred into mice 
lacking all m  and DC, Ly6C hi monocytes give rise to a 
population of CD11b+ CD11c+ CX3CR1+ E-cadherin+ 
class II MHC+ m  in the mucosa. These can produce 
copious amounts of TNF-  and other inflammatory me-
diators  [7, 27, 28, 97] .
 A similar recruitment of cytokine producing mono-
cyte-derived CD14+ m  is seen in the lesions of active 
Crohn’s disease in man  [21, 24, 51, 61, 88] and so there is 
considerable interest in exploiting the mechanisms re-
sponsible as targets for therapy. The Ly6C hi monocytes 
that give rise to inflammatory m  in the mouse intestine 
are CCR2+ and their accumulation is dependent on this 
chemokine receptor in the same way as it is in other in-
flamed sites  [8, 49] . In parallel, increased levels of CCR2 
ligands can be found in inflamed mucosa and experimen-
tal colitis in mice is abolished in CCR2 KO mice  [8, 10] . 
Other factors that may contribute to the recruitment of 
inflammatory m  include CCR5  [98, 99] and enhanced 
expression of the adhesion molecules P-selectin glycopro-
tein ligand-1, VCAM-1, CD31 and ICAM-1 on endothe-
lial cells in the inflamed mucosa  [100, 101] . The progeny 
of Ly6C hi monocytes in T cell-dependent colitis in mice 
also express CCR6  [97] , whose ligand CCL20 is present in 
the intestine, but it is not known if CCR6 is required for 
the recruitment of inflammatory m  to the intestine. It 
has also been reported that mice lacking the CX3CR1 che-
mokine receptor have a defect in the recruitment of m  
to the inflamed colon and spleen, as well as being resistant 
to experimental colitis  [3, 49, 102] . Thus, several different 
factors may play redundant and/or overlapping roles in 
recruiting monocytes to the inflamed gut.
 Ontogeny and Recruitment of Resident 
Intestinal M  
 The origins of the resident population of m  found in 
healthy intestine have been less easy to identify ( fig. 4 ), 
but their presence is dependent on the myeloid growth 
factors CSF-1 and GM-CSF, and independent of the DC-
specific flt3 tyrosine kinase receptor  [7, 9, 27] . In mice, it 
is believed that a discrete population of CX3CR1+ Ly6C– 
monocyte gives rise to tissue resident m   [49] . However, 
the entry of such monocytes into the intestine has never 
been shown directly. Indeed the only study to have ex-
amined this could not find any progeny of transferred 
CX3CR1+ Ly6C– monocytes in the intestine, even in 
mice depleted of all m  and DC  [28] . As kinetic studies 
indicate that resident CX3CR1+ m  turn over very slow-
ly in vivo  [14, 16] , the entry of their precursors into the 
normal gut may be a relatively rare event and difficult to 
demonstrate experimentally. Somewhat surprisingly, in-
flammatory Ly6C hi monocytes have been shown to re-
populate  intestinal m  in the absence of overt inflam-
mation, although this can only be seen when the resident 
popula tions have been ablated for example by irradiation 
or diphtheria toxin-mediated depletion of CD11c+ my-
eloid cells  [7, 27] . One interpretation of this is that the 
antigenic challenge faced by the normal intestine may 
make it behave like an ‘inflamed’ tissue in terms of its 
m  renewal. Certainly this would be consistent with the 
fact that all resident m  in mouse mucosa express CCR2 
[ 26 , unpubl. observations], a receptor that is normally as-
sociated specifically with the inflammatory Ly6C hi sub-
set of monocyte. Although it is difficult to exclude the 
possibility that the conditioning regimes necessary to 
demonstrate entry of m  into the otherwise healthy in-
testine induce mild inflammation, the entry of IL-10-
producing m  into normal mouse intestine is dependent 
on the chemokine CCL2, one of the ligands for CCR2 
 [103] . Therefore, the monocytes that give rise to m  in 
resting intestine may be distinct from those that replen-
ish other tissues.
 Given these issues, it is not surprising that the factors 
responsible for recruiting resident m  to the healthy gut 
are also unclear. Although it has been shown that TGF-  
and IL-8 produced by intestinal stromal cells may act as 
chemotactic factors for resting monocytes  [104] , the role 
of these factors in recruiting resident intestinal m  in 
vivo  has yet to be proved. Despite the high levels of ex-
pression of CX3CR1 on resident mucosal m  and its pos-
sible role in recruiting inflammatory m  , the CX3CR1-
CX3CL1 axis does not seem to play an essential role in 
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m  recruitment to the healthy intestine, as CX3CR1 KO 
mice have normal populations of resident m  [ 28 ,  105 , 
unpubl. observations]. However, as noted above, CCR2 
may play a counter-intuitive role in recruiting both resi-
dent and inflammatory m  in contrast to its pro-inflam-
matory role in other tissues. 
 Self-Renewal of Intestinal M  as a Local Mechanism 
of Replenishment 
 One possible explanation for the difficulties in iden-
tifying the precursors of resident intestinal m  is that 
they could be replenished by local self-renewal in situ 
Inflamed mucosaResting mucosa
TLR ligands
Commensal
microorganisms Apoptotic
epithelium
Pathogenic
microorganisms
Epithelium
CX3CL1 CCL2
TNF-
IL-6
IL-1
IL-12
IL-23
Local
proliferation?
Resident M
TGF-
TGF-R
FoxP3+
regulatory T
cell
Ly6Clo CX3CR1+
monocytes
IL-10
CX3CR1
MHC class ll
MHC class ll
CX3CR1
CCR2
Effector
T cell
Inflammatory M
Ly6Chi CCR2+
monocytes
?
?
?
TLR
 Fig. 4. Origin and diversity of intestinal m  in healthy and in-
flamed intestine. In resting intestine, the majority of intestinal 
m  express high levels of CX3CR1, the receptor for the trans-
membrane chemokine fractalkine (CX3CL1) expressed by intes-
tinal epithelial cells. These m  can ingest and kill commensal 
bacteria, perhaps by extending processes across the epithelial bar-
rier into the lumen. They produce IL-10 constitutively, but are 
unable to produce pro-inflammatory mediators in response to 
TLR or other stimuli. This means that resident intestinal m  can-
not assist effector T cell activity, but instead, their production of 
IL-10 is needed to maintain the survival of local FoxP3+ Treg. In 
turn, the Treg produce TGF-  which, together with IL-10 and 
other local factors, maintain resident m  in their state of partial 
inertia. This may also require TLR signalling from the commen-
sal microbiota. The resident m  are long-lived, and may be 
replenished directly from the bloodstream either by resident 
CX3CR1+ Ly6C lo monocytes or by inflammatory CX3CR1 lo 
Ly6C hi monocytes. There may also be local turnover of resident 
m  , or differentiation of the small numbers of CX3CR1 int inflam-
matory m  present in normal mucosa (see text for details). After 
breach of the epithelial barrier, or pathogenic invasion, the mu-
cosa is infiltrated by large numbers of inflammatory m  which 
express lower levels of CX3CR1. These CX3CR1 int m  are derived 
from recently divided inflammatory CX3CR1 lo Ly6C hi CCR2+ 
monocytes in the bloodstream, recruited in response to increased 
levels of CCR2 ligands. The CX3CR1 int m  produce large amounts 
of pro-inflammatory mediators that drive local inflammation 
and promote the function of effector T cells. Some inflammatory 
CX3CR1 int m  may eventually differentiate into resident 
CX3CR1 hi m  to assist resolution of damage. 
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( fig. 4 ). This is known to occur with some other mono-
nuclear cell populations, including microglia in the cen-
tral nervous system and Kupffer cells in the liver, as well 
as for the DC-related Langerhans cells in the epidermis 
of the skin  [49, 106–108] . In these cases, the resident pop-
ulation is established before, or just after birth, by a my-
eloid precursor which subsequently self-renews. There 
may also be a contribution from blood-derived mono-
cytes throughout normal adult life and, during inflam-
mation, there is an intense recruitment of inflammatory 
monocytes that dilutes out the resident m  population, 
as occurs in inflamed intestine  [26] . The possibility that 
self-renewing m  may exist in the gut has not been
addressed directly, but adoptively transferred Ly6C hi 
monocytes appeared to undergo clonal expansion in vil-
lus mucosa in m  /DC-depleted recipients  [28] . In addi-
tion, mucosal m  are absent in CSF-1 receptor KO mice 
and after antibody-mediated neutralisation of CSF-1R  [9, 
27] , despite the fact that blood monocytes can repopulate 
other tissue m  in CSF-1R KO mice  [108] . Thus, the 
need for CSF-1 may be in maturation of local precursors 
 [9] , and if these findings can be confirmed in physiolog-
ical conditions, they would suggest that self-renewal of 
m  might be an important process in the healthy intes-
tine.
 CX3CR1 Expression as a Marker of Resident and 
Inflammatory M  in the Intestine 
 One of the reasons so little is known about the origins 
and recruitment of resident and inflammatory m  in the 
intestine has been the lack of precise phenotypic markers 
with which to distinguish these cells. Very recent work 
may provide some novel insights into this, by showing 
that two distinct subsets of inflammatory and resident 
m  can be identified in the intestine on the basis of their 
level of CX3CR1 expression [ 26 , unpubl. observations]. In 
the resting state, the majority of mucosal m  express lev-
els of CX3CR1 that are higher than any other myeloid 
population ( fig.  2 ), and this resident subset expresses 
mRNA for anti-inflammatory factors such as IL-10, 
Homx1 and the mannose receptor; it is also unresponsive 
to stimulation in vitro  [26] . The ‘inert’ status of these
CX3CR1 hi m  changes little during inflammation, when 
they are diluted out by a TLR-responsive population 
which expresses lower levels of CX3CR1, as well as pro-
ducing TNF-  and other inflammatory mediators such 
as IL-6 and iNOS  [26] . Both subsets are CD11b hi F4/80+ 
class II MHC+ and are heterogeneous for CD11c expres-
sion, meaning they cannot be distinguished on the basis 
of these conventional markers. Interestingly, a small 
number of these CX3CR1 int m  is also found in the nor-
mal intestine and it is tempting to speculate that it is these 
active cells which account for the homeostatic functions 
of m  in the healthy gut. 
 Conclusions 
 M  are a fundamental component of the innate im-
mune system in the healthy and inflamed intestine, 
where they play essential roles in homeostasis and dis-
ease. In normal gut, they are held in a state of partial in-
ertia, but this changes rapidly during inflammation, by 
as yet  unknown mechanisms. Although mucosal m  are 
now clearly heterogeneous in nature, it is not known 
whether inflammation reflects plasticity within individ-
ual subsets or is due to changes in the balance of their 
recruitment. Importantly, although inflammatory m  
seem to be derived from Ly6C hi monocytes, the precursor 
of resident intestinal m  has not been identified directly. 
Whether this is the CX3CR1+ ‘resident’ monocyte, 
whether they are generated from local conditioning of 
initially inflammatory m  or whether they are main-
tained by local turnover and renewal, as can occur with 
some m  in other tissues are important questions for fu-
ture work. These crucial studies will inform the specific-
ity and safety of new therapeutic strategies aimed at tar-
geting the recruitment and/or activation of one or other 
of the m  subsets.
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